Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.05
LPNT's Cash to Debt is ranked lower than
77% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.32 vs. LPNT: 0.05 )
LPNT' s 10-Year Cash to Debt Range
Min: 0.01   Max: 0.38
Current: 0.05

0.01
0.38
Equity to Asset 0.075
LPNT's Equity to Asset is ranked lower than
64% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. LPNT: 0.075 )
LPNT' s 10-Year Equity to Asset Range
Min: -0.05   Max: 0.45
Current: 0.08

-0.05
0.45
Interest Coverage 16
LPNT's Interest Coverage is ranked lower than
79% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. LPNT: 16 )
LPNT' s 10-Year Interest Coverage Range
Min: 2   Max: 16
Current: 16

2
16
F-Score: 7
Z-Score: 1.92
M-Score: -3.26
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 34.50
LPNT's Operating margin (%) is ranked lower than
71% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. LPNT: 34.50 )
LPNT' s 10-Year Operating margin (%) Range
Min: 8.4   Max: 34.5
Current: 34.5

8.4
34.5
Net-margin (%) 3.3
LPNT's Net-margin (%) is ranked lower than
58% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. LPNT: 3.3 )
LPNT' s 10-Year Net-margin (%) Range
Min: -1.4   Max: 8.6
Current: 3.3

-1.4
8.6
ROE (%) 7.4
LPNT's ROE (%) is ranked lower than
67% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 11.20 vs. LPNT: 7.4 )
LPNT' s 10-Year ROE (%) Range
Min: -8.6   Max: 17.4
Current: 7.4

-8.6
17.4
ROA (%) 3.2
LPNT's ROA (%) is ranked lower than
66% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 4.60 vs. LPNT: 3.2 )
LPNT' s 10-Year ROA (%) Range
Min: -1.8   Max: 9.7
Current: 3.2

-1.8
9.7
ROC (Joel Greenblatt) (%) 65.60
LPNT's ROC (Joel Greenblatt) (%) is ranked lower than
71% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 17.40 vs. LPNT: 65.60 )
LPNT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.3   Max: 65.6
Current: 65.6

13.3
65.6
Revenue Growth (%) 14.9
LPNT's Revenue Growth (%) is ranked higher than
63% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 4.50 vs. LPNT: 14.9 )
LPNT' s 10-Year Revenue Growth (%) Range
Min: 4.2   Max: 16.8
Current: 14.9

4.2
16.8
EBITDA Growth (%) 43
LPNT's EBITDA Growth (%) is ranked higher than
79% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 4.70 vs. LPNT: 43 )
LPNT' s 10-Year EBITDA Growth (%) Range
Min: 2.8   Max: 43
Current: 43

2.8
43
EPS Growth (%) 6
LPNT's EPS Growth (%) is ranked higher than
77% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. LPNT: 6 )
LPNT' s 10-Year EPS Growth (%) Range
Min: -4.7   Max: 34.4
Current: 6

-4.7
34.4
ยป LPNT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2012

LPNT Guru Trades in Q2 2012

Richard Snow 22,500 sh (New)
Chuck Royce 243,000 sh (New)
Paul Tudor Jones 10,000 sh (+26.58%)
Larry Robbins 1,449,040 sh (+15.11%)
Diamond Hill Capital 581,143 sh (+0.94%)
HOTCHKIS & WILEY 1,171,000 sh (-0.08%)
David Dreman 885,695 sh (-1.42%)
Steven Cohen 9,948 sh (-63.32%)
Jim Simons 9,830 sh (-65.06%)
» More
Q3 2012

LPNT Guru Trades in Q3 2012

Larry Robbins 2,402,277 sh (+65.78%)
Chuck Royce 303,000 sh (+24.69%)
Richard Snow 22,500 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
HOTCHKIS & WILEY 1,158,100 sh (-1.1%)
Diamond Hill Capital 570,488 sh (-1.83%)
David Dreman 865,150 sh (-2.32%)
Paul Tudor Jones 9,300 sh (-7%)
» More
Q4 2012

LPNT Guru Trades in Q4 2012

Steven Cohen 262,256 sh (New)
Paul Tudor Jones 16,900 sh (+81.72%)
HOTCHKIS & WILEY 1,869,900 sh (+61.46%)
Diamond Hill Capital 575,205 sh (+0.83%)
Jeremy Grantham 14,245 sh (unchged)
Larry Robbins 2,402,277 sh (unchged)
Chuck Royce Sold Out
Richard Snow Sold Out
David Dreman 848,559 sh (-1.92%)
» More
Q1 2013

LPNT Guru Trades in Q1 2013

Ray Dalio 38,407 sh (New)
Larry Robbins 3,620,895 sh (+50.73%)
Jeremy Grantham 15,035 sh (+5.55%)
David Dreman 812,199 sh (-4.28%)
Paul Tudor Jones 10,900 sh (-35.5%)
Steven Cohen 133,557 sh (-49.07%)
HOTCHKIS & WILEY 847,300 sh (-54.69%)
Diamond Hill Capital 87,338 sh (-84.82%)
» More
» Details

Insider Trades

Latest Guru Trades with LPNT

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
HOTCHKIS & WILEY 2013-03-31 Reduce -54.69%0.22%$37.75 - $48.5 $ 47.388%847300
Ray Dalio 2013-03-31 New Buy0.02%$37.75 - $48.5 $ 47.388%38407
HOTCHKIS & WILEY 2012-12-31 Add 61.46%0.16%$35.19 - $43.41 $ 47.3824%1869900
Richard Snow 2012-12-31 Sold Out 0.05%$35.19 - $43.41 $ 47.3824%0
Richard Snow 2012-06-30 New Buy0.05%$34.58 - $41.17 $ 47.3825%22500
Richard Snow 2012-03-31 Sold Out 1.4%$35.58 - $41.63 $ 47.3830%0
Joel Greenblatt 2012-03-31 Sold Out 0.12%$35.58 - $41.63 $ 47.3830%0
HOTCHKIS & WILEY 2012-03-31 Add 43.05%0.08%$35.58 - $41.63 $ 47.3830%1171900
Richard Snow 2011-12-31 Reduce -50.76%1.5%$33.44 - $40.34 $ 47.3826%762551
Joel Greenblatt 2011-12-31 New Buy0.12%$33.44 - $40.34 $ 47.3826%27684
Ray Dalio 2011-12-31 Sold Out 0.11%$33.44 - $40.34 $ 47.3826%0
Ray Dalio 2011-09-30 Add 107.95%0.06%$29.16 - $40.43 $ 47.3834%203274
George Soros 2011-09-30 Sold Out 0.0325%$29.16 - $40.43 $ 47.3833%0
George Soros 2011-06-30 Add 556.67%0.03%$37.88 - $43.27 $ 47.3818%59100
Andreas Halvorsen 2011-03-31 Sold Out 0.25%$34.84 - $39.9 $ 47.3827%0
HOTCHKIS & WILEY 2011-03-31 Add 267.19%0.17%$34.84 - $39.9 $ 47.3827%1074400
John Hussman 2011-03-31 Sold Out $34.84 - $39.9 $ 47.3827%0
Andreas Halvorsen 2010-12-31 New Buy0.25%$33.28 - $37.575 $ 47.3833%823452
HOTCHKIS & WILEY 2010-09-30 Reduce -32.37%0.03%$29.71 - $36.69 $ 47.3848%292600
George Soros 2010-09-30 Reduce -42.86%$29.71 - $36.69 $ 47.3848%8000
John Hussman 2010-06-30 Reduce -30.43%0.05%$31.76 - $39.27 $ 47.3833%327000
HOTCHKIS & WILEY 2010-06-30 Reduce -24.34%0.02%$31.76 - $39.27 $ 47.3833%432673
Richard Snow 2010-03-31 Add 34.08%0.66%$29.02 - $37.91 $ 47.3846%1898163
George Soros 2010-03-31 New Buy0.01%$29.02 - $37.91 $ 47.3846%13800
Premium More recent guru trades are included for Premium Members only!!

Top Ranked Articles about LifePoint Hospitals, Inc.

Larry Robbins Increases LifePoint Stake to 6.7% Ahead of Earnings Announcement Larry Robbins - Larry Robbins Increases LifePoint Stake To 6.7% Ahead Of Earnings Announcement
Larry Robbins added 32.64% to his holding of LifePoint Hospitals Inc. (LPNT) at the average price of $44.21 on Feb. 14, 2013, as reported by GuruFocus Real Time Picks. He now owns 3,186,280 shares, or 6.71% of the company. The stock price has changed by -3%. LifePoint Hospitals Inc., a Delaware corporation, acting through its subsidiaries, operates general acute care hospitals primarily in non-urban communities in the U.S. Read more...
LifePoint Hospitals... Not Healthy for Your Portfolio
Nowadays, it would be quite the task to turn on the television and not be bombarded by the latest medical drama/comedy on TV. Seemingly the newest craze, one must not forget that hospitals arenโ€™t always purely altruistic but can exist as a publicly traded company aimed at delivering the greatest value to their shareholders. While the ethical premise of business with respect to healthcare is a hotly debated topic, like all organizations, hospitals depend on revenues to maintain and facilitate growth. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 17.80
LPNT's P/E(ttm) is ranked higher than
75% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 16.20 vs. LPNT: 17.80 )
LPNT' s 10-Year P/E(ttm) Range
Min: 8.83   Max: 92.82
Current: 17.8

8.83
92.82
P/B 1.08
LPNT's P/B is ranked higher than
79% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.99 vs. LPNT: 1.08 )
LPNT' s 10-Year P/B Range
Min: 0.57   Max: 13.55
Current: 1.08

0.57
13.55
P/S 0.48
LPNT's P/S is ranked higher than
58% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.81 vs. LPNT: 0.48 )
LPNT' s 10-Year P/S Range
Min: 0.35   Max: 2.98
Current: 0.48

0.35
2.98
PFCF 11.23
LPNT's PFCF is ranked lower than
55% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 14.34 vs. LPNT: 11.23 )
LPNT' s 10-Year PFCF Range
Min: 6.04   Max: 87.1
Current: 11.23

6.04
87.1
EV-to-EBIT 2.43
LPNT's EV-to-EBIT is ranked lower than
58% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 13.20 vs. LPNT: 2.43 )
LPNT' s 10-Year EV-to-EBIT Range
Min: 2.1   Max: 29.7
Current: 2.43

2.1
29.7
PEG 0.48
LPNT's PEG is ranked higher than
95% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. LPNT: 0.48 )
LPNT' s 10-Year PEG Range
Min: 0.55   Max: 2.4
Current: 0.48

0.55
2.4
Shiller P/E 16.96
LPNT's Shiller P/E is ranked higher than
82% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 11.50 vs. LPNT: 16.96 )
LPNT' s 10-Year Shiller P/E Range
Min: 8.54   Max: 43.95
Current: 16.96

8.54
43.95

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 5.8
LPNT's Price/Net Current Asset Value is ranked higher than
59% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 6.55 vs. LPNT: 5.8 )
LPNT' s 10-Year Price/Net Current Asset Value Range
Min: 4.8   Max: 58.3
Current: 5.8

4.8
58.3
Price/Tangible Book 6.3
LPNT's Price/Tangible Book is ranked higher than
85% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 2.70 vs. LPNT: 6.3 )
LPNT' s 10-Year Price/Tangible Book Range
Min: 3.8   Max: 22.3
Current: 6.3

3.8
22.3
Price/DCF (Projected) 0.5
LPNT's Price/DCF (Projected) is ranked higher than
77% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.80 vs. LPNT: 0.5 )
LPNT' s 10-Year Price/DCF (Projected) Range
Min: 0.4   Max: 2.4
Current: 0.5

0.4
2.4
Price/Median PS Value 0.6
LPNT's Price/Median PS Value is ranked higher than
66% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 0.90 vs. LPNT: 0.6 )
LPNT' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 3.5
Current: 0.6

0.5
3.5
Price/Peter Lynch Fair Value 1
LPNT's Price/Peter Lynch Fair Value is ranked lower than
71% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. LPNT: 1 )
LPNT' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7   Max: 2.2
Current: 1

0.7
2.2
Price/Graham Number 1.9
LPNT's Price/Graham Number is ranked higher than
92% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. LPNT: 1.9 )
LPNT' s 10-Year Price/Graham Number Range
Min: 1.6   Max: 9.6
Current: 1.9

1.6
9.6
Earnings Yield (Greenblatt) 41.20
LPNT's Earnings Yield (Greenblatt) is ranked higher than
54% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. LPNT: 41.20 )
LPNT' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.4   Max: 47.6
Current: 41.2

3.4
47.6
Forward Rate of Return (Yacktman) 27.59
LPNT's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 11.99 vs. LPNT: 27.59 )
LPNT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 11.5   Max: 29.2
Current: 27.59

11.5
29.2

Business Description

LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates general acute care hospitals primarily in non-urban communities in the United States. At December 31, 2011, on a consolidated basis, the Company operated 54 hospital campuses in 18 states. The Company's hospitals typically provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services, pediatric services, and, in some of the Company's hospitals, specialized services such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. In many markets, it also provides outpatient services such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy. The services provided at any specific hospital depend on factors such as community need for the service, whether physicians necessary to operate the service line safely are members of the medical staff of that hospital, whether the service might be economically viable, and any contractual or certificate of need restrictions that might exist. Like most hospitals located in non-urban markets, its hospitals do not engage in extensive medical research and medical education programs. However, two of the Company's hospitals have an affiliation with medical schools, including the clinical rotation of medical students, and one of its hospitals owns and operates a school of health professions with a nursing program and a radiologic technology program. The Company maintains quality assurance programs to support and monitor quality of care standards and to meet accreditation and regulatory requirements. The Company also monitors patient care evaluations and other quality of care assessment activities on a regular basis. The Company's hospitals and other healthcare businesses operate in extremely competitive environments. The Company's healthcare operations generate medical waste that must be disposed of in compliance with federal, state and local environmental laws, rules and regulations. Its operations, as well as the purchases and sales of healthcare facilities, are also subject to compliance with various other environmental laws, rules and regulations.
Company Website
SEC Reports
Industry: Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF
Traded in other countries:LPO.Germany

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial